In regard to Sherertz et al., IJROBP 2001; 51:1241-1245

Comment

Alan Pollack et al. Int J Radiat Oncol Biol Phys. 2002.

. 2002 Jun 1;53(2):512; author reply 512.

doi: 10.1016/s0360-3016(02)02774-8.

No abstract available

Comment on

Dose selection for prostate cancer patients based on dose comparison and dose response studies.
Hanks GE, Hanlon AL, Pinover WH, Horwitz EM, Price RA, Schultheiss T. Hanks GE, et al. Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):823-32. doi: 10.1016/s0360-3016(99)00498-8. Int J Radiat Oncol Biol Phys. 2000. PMID: 10705002
Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial.
Storey MR, Pollack A, Zagars G, Smith L, Antolak J, Rosen I. Storey MR, et al. Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):635-42. doi: 10.1016/s0360-3016(00)00700-8. Int J Radiat Oncol Biol Phys. 2000. PMID: 11020558 Clinical Trial.
Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life.
Kupelian PA, Reddy CA, Klein EA, Willoughby TR. Kupelian PA, et al. Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):988-93. doi: 10.1016/s0360-3016(01)01730-8. Int J Radiat Oncol Biol Phys. 2001. PMID: 11704322
Long-term urinary function after transperineal brachytherapy for patients with large prostate glands.
Sherertz T, Wallner K, Wang H, Sutlief S, Russell K. Sherertz T, et al. Int J Radiat Oncol Biol Phys. 2001 Dec 1;51(5):1241-5. doi: 10.1016/s0360-3016(01)01738-2. Int J Radiat Oncol Biol Phys. 2001. PMID: 11728683